CNS‐directed therapy in young children with T‐lineage acute lymphoblastic leukemia: High‐dose methotrexate versus cranial irradiation

Abstract

The use of HD-MTX instead of CRT as CNS-directed therapy in very young children with T-ALL does not compromise survival, while avoiding the adverse long-term effects of cranial irradiation.